Published in Nature on April 08, 1993
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Comparative genomics of foot-and-mouth disease virus. J Virol (2005) 3.42
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol (1997) 2.51
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A (1994) 2.49
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol (2000) 2.24
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol (2002) 1.60
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol (1998) 1.52
Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc Natl Acad Sci U S A (2000) 1.46
Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol (2000) 1.44
Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol (2004) 1.36
Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol (2000) 1.32
Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol (1993) 1.26
Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol (1995) 1.23
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol (1994) 1.23
Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus. Structure (2008) 1.22
Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol (1994) 1.21
A Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular Tools. Vet Med Int (2011) 1.19
Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J Virol (2000) 1.18
Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol (2006) 1.16
Tumor Targeting via Integrin Ligands. Front Oncol (2013) 1.15
Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol (2003) 1.11
Equine rhinitis A virus and its low pH empty particle: clues towards an aphthovirus entry mechanism? PLoS Pathog (2009) 1.09
Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus. J Virol (2001) 1.07
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. J Virol (2001) 1.06
Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol (2007) 1.06
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J Virol (1997) 1.06
Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7. J Virol (1996) 1.06
Enhanced conformational sampling in Monte Carlo simulations of proteins: application to a constrained peptide. Proc Natl Acad Sci U S A (1995) 1.04
Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol (2005) 1.04
Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J Virol (2004) 1.03
Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. J Virol (1994) 1.02
A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J Virol (1998) 1.01
High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit. J Virol (2000) 0.98
PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments. Biomed Res Int (2014) 0.98
Low temperature and pressure stability of picornaviruses: implications for virus uncoating. Biophys J (1999) 0.96
Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host. J Virol (2007) 0.93
Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus. J Gen Virol (2014) 0.91
The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey. BMC Vet Res (2006) 0.91
Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses. Vaccine (2014) 0.91
Crystal structure of Swine vesicular disease virus and implications for host adaptation. J Virol (2003) 0.90
Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure. J Mol Evol (1998) 0.90
Disulfide bonding among micro 1 trimers in mammalian reovirus outer capsid: a late and reversible step in virion morphogenesis. J Virol (2003) 0.89
Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus. PLoS One (2013) 0.88
Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East. Vaccine (2013) 0.88
Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. J Virol (2003) 0.87
Crystal structure of bovine angiogenin at 1.5-A resolution. Proc Natl Acad Sci U S A (1995) 0.86
The Structure of Human Parechovirus 1 Reveals an Association of the RNA Genome with the Capsid. J Virol (2015) 0.86
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. J Mol Biol (2008) 0.85
Characterization of epitope-tagged foot-and-mouth disease virus. J Gen Virol (2012) 0.85
Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions. J Virol (1996) 0.84
Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins. Protein Sci (2001) 0.84
Monoclonal and polyclonal antibodies specific for foot and mouth disease virus type A and type O VP1. Hybridoma (Larchmt) (2012) 0.83
Foot-and-mouth disease virus replicates only transiently in well-differentiated porcine nasal epithelial cells. J Virol (2010) 0.83
In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol (2011) 0.81
Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding. J Virol (1997) 0.81
Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability. PLoS One (2013) 0.81
The solution structure of PapGII from uropathogenic Escherichia coli and its recognition of glycolipid receptors. EMBO Rep (2001) 0.80
Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1. Adv Appl Bioinform Chem (2013) 0.79
Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles. J Virol (2013) 0.79
Demystified ... adhesion molecules. Mol Pathol (1998) 0.78
NMR relaxation and structural elucidation of peptides in the presence and absence of trifluoroethanol illuminates the critical molecular nature of integrin αvβ6 ligand specificity. RSC Adv (2012) 0.78
The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake. J Nucl Med (2015) 0.78
Development of a quick and simple detection methodology for foot-and-mouth disease virus serotypes O, A and Asia 1 using a generic RapidAssay Device. Virol J (2013) 0.78
Examination of soluble integrin resistant mutants of foot-and-mouth disease virus. Virol J (2013) 0.78
Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. J Virol (2014) 0.77
Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. Arch Virol (2013) 0.77
Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus. J Virol (1996) 0.77
Q2DSTD NMR deciphers epitope-mapping variability for peptide recognition of integrin αvβ6. Org Biomol Chem (2015) 0.77
Induction of partial protection against foot and mouth disease virus in guinea pigs by neutralization with the integrin β6-1 subunit. Viruses (2013) 0.77
Genetic characterization of the cell-adapted PanAsia strain of foot-and-mouth disease virus O/Fujian/CHA/5/99 isolated from swine. Virol J (2010) 0.76
Identification and Genome Characterization of the First Sicinivirus Isolate from Chickens in Mainland China by Using Viral Metagenomics. PLoS One (2015) 0.75
Agroinfiltration contributes to VP1 recombinant protein degradation. Bioengineered (2016) 0.75
Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis. Virol J (2016) 0.75
Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus. Clin Vaccine Immunol (2012) 0.75
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells. Mol Ther (2017) 0.75
Identification of a novel cell culture adaptation site on the capsid of foot-and-mouth disease virus. J Gen Virol (2015) 0.75
In vitro evolution and affinity-maturation with Coliphage qβ display. PLoS One (2014) 0.75
How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection. Virol J (2015) 0.75
Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis. PLoS One (2016) 0.75
Evolutionary analysis of structural protein gene VP1 of foot-and-mouth disease virus serotype Asia 1. ScientificWorldJournal (2015) 0.75
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother (1973) 8.83
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrob Agents Chemother (1982) 6.97
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79
Cytogenetic Analysis of Chromosome 3 in DROSOPHILA MELANOGASTER: The Homoeotic Gene Complex in Polytene Chromosome Interval 84a-B. Genetics (1980) 5.39
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ (2001) 4.49
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob Agents Chemother (1980) 4.43
Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 4.16
Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet (1998) 4.16
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
API ZYM: a simple rapid system for the detection of bacterial enzymes. J Clin Pathol (1977) 3.88
In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob Agents Chemother (1980) 3.68
Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother (1976) 3.55
Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum (1996) 3.53
Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol (1994) 3.44
Structure of translation initiation factor 5A from Pyrobaculum aerophilum at 1.75 A resolution. Structure (1998) 3.16
How effective is tailored print communication? Ann Behav Med (1999) 3.10
Generic inhalers for asthma. BMJ (1994) 3.09
Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun (1996) 3.09
Multi-level analysis in epidemiologic research on health behaviors and outcomes. Am J Epidemiol (1992) 2.94
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet (2000) 2.82
Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol (2000) 2.74
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother (1995) 2.62
The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother (1986) 2.59
Anaesthesia of capuchin monkeys. Vet Rec (1994) 2.57
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet (2000) 2.51
Three-dimensional grain mapping by x-ray diffraction contrast tomography and the use of Friedel pairs in diffraction data analysis. Rev Sci Instrum (2009) 2.49
The relationship between chromosome structure and function at a human telomeric region. Nat Genet (1997) 2.48
The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess (2000) 2.45
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Is screening mammography effective in elderly women? Am J Med (2000) 2.38
Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J Biol Chem (2000) 2.37
Methemoglobinemia. Ann Emerg Med (1982) 2.33
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
Extreme diversity, conservation, and convergence of spider silk fibroin sequences. Science (2001) 2.27
Reliability of the health hazard appraisal. Am J Public Health (1980) 2.26
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol (2000) 2.24
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother (1986) 2.16
Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol (2000) 2.15
MDM2 gene amplification in metastatic osteosarcoma. Cancer Res (1993) 2.15
Structural and compositional changes associated with chlorine inactivation of polioviruses. Appl Environ Microbiol (1979) 2.15
Management of heart disease in the elderly in the Plymouth Health District. J R Coll Physicians Lond (1995) 2.13
Failure to control venereal disease. Br Med J (1970) 2.10
Angular malalignment after intramedullary nailing of femoral shaft fractures. J Orthop Trauma (2001) 2.08
Evaluation of sponging to reduce body temperature in febrile children. Can Med Assoc J (1985) 2.07
The first Harrison Lecture, 1974. The life and times of Colonel Harrison. Br J Vener Dis (1974) 2.00
Epizootiology of avian influenza--simultaneous monitoring of sentinel ducks and turkeys in Minnesota. Avian Dis (1983) 1.98
The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. J Antimicrob Chemother (1976) 1.96
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. J Antimicrob Chemother (1985) 1.96
Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method. J Antimicrob Chemother (2000) 1.95
Poly(C) in animal viral RNAs. Nature (1974) 1.95
Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J Biol Chem (2001) 1.93
Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Hum Genet (1986) 1.92
Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in Central Arizona. Acad Emerg Med (2001) 1.88
Evolution of European bat lyssaviruses. J Gen Virol (1997) 1.86
The determinants of health care expenditure: a cointegration approach. J Health Econ (1996) 1.85
Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci (1995) 1.83
A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. Bull World Health Organ (2001) 1.83
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
The structure and antigenicity of a type C foot-and-mouth disease virus. Structure (1994) 1.82
Venous thromboembolism after acute stroke. Stroke (2001) 1.81
Comparison of radiometric and gas capture system for blood cultures. J Clin Pathol (1986) 1.81
Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (1999) 1.79
European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79
Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol (1997) 1.79
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine (2001) 1.79
A longitudinal analysis of unaided smoking cessation. J Consult Clin Psychol (1988) 1.78
Hydrodynamic properties and structure of fd virus. J Mol Biol (1977) 1.77
Epidemic multiresistant Escherichia coli infection in West Lambeth Health District. Lancet (1988) 1.76
Patterns of walker use and walker injury. Pediatrics (1986) 1.73
Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine (2000) 1.71
Clinical versus administrative data bases for CABG surgery. Does it matter? Med Care (1992) 1.70
Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development (1995) 1.69
The impaired driver: hospital and police detection of alcohol and other drugs of abuse in motor vehicle crashes. Ann Emerg Med (1994) 1.68
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Arch Dermatol (1993) 1.68
Structure of tandem RNA recognition motifs from polypyrimidine tract binding protein reveals novel features of the RRM fold. EMBO J (2000) 1.67
Dynamic light-scattering evidence for the flexibility of native muscle thin filaments. Biophys J (1980) 1.67
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
A complication of ilio-inguinal block for inguinal hernia repair. Anaesthesia (1988) 1.65
Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J Mol Biol (2001) 1.65
A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med (2002) 1.65
Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates. Br J Haematol (1971) 1.64
Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J AOAC Int (1995) 1.63
Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature (1988) 1.63
The sensitivity, specificity and predictive values of raised plasma metal ion levels in the diagnosis of adverse reaction to metal debris in symptomatic patients with a metal-on-metal arthroplasty of the hip. J Bone Joint Surg Br (2012) 1.62
Do communities differ in health behaviors? J Clin Epidemiol (1993) 1.60
Analysis of survival versus patient and doctor delay of treatment in gastrointestinal cancer. Am J Surg (1974) 1.57
Activity of an alcohol-based hand gel against human adeno-, rhino-, and rotaviruses using the fingerpad method. Infect Control Hosp Epidemiol (2000) 1.57